First simulation-based evaluation of kesterite as a hole transport layer in antimony chalcogenide solar cells
Physica Scripta · 01.12.2025 · 100 (12) · 125534
DOI: 10.1088/1402-4896/ae296f ↗Kurz gefasst
Fachartikel in der Zeitschrift Physica Scripta, online erschienen am 18.12.2025. Verfasst von Mohd Haniff Ibrahim und 1 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Universiti Teknologi Malaysia, Potential Academic Staff.
Abstract (Originalsprache)
There has been growing interest in antimony chalcogenide (AC) solar cells owing to the advantages of their absorber materials, yet their performance remains limited by interfacial losses. Although conventional hole transport layers (HTLs) such as Spiro-OMeTAD have been widely employed in AC solar cells, their cost and durability remain limiting factors. In this work, we present the first simulation-based evaluation of kesterite compounds as HTLs in AC solar cells comprising antimony sulfide (Sb 2 S 3 ) and antimony selenide (Sb 2 Se 3 ) absorbers. Three candidates, namely Cu 2 ZnGeS 4 (CZGS), Cu 2 BaSnS 4 (CBTS), and Cu 2 FeSnS 4 (CFTS), were investigated using the SCAPS-1D platform and benchmarked against the conventional Spiro-OMeTAD. TiO 2 and ZnS were incorporated as electron transport layers (ETLs), and device performance was assessed with emphasis on band alignment, layer thickness, and key photovoltaic parameters. Results show that favourable valence-band alignment with CZGS and CBTS enables efficient hole extraction and suppressed recombination, leading to higher efficiencies than Spiro-OMeTAD. For CZGS, CBTS, and Spiro-OMeTAD, optimum absorber thicknesses were 600 nm for Sb 2 Se 3 and 800 nm for Sb 2 S 3 , while CFTS required thinner absorbers (300 nm and 500 nm) but exhibited inferior performance. Simulated absorbance and external quantum efficiency (EQE) spectra revealed that TiO 2 , ZnS, CBTS, and CZGS exhibit strong optical transparency, while CFTS suffers from parasitic absorption that suppressed photo-response. Both Sb 2 S 3 and Sb 2 Se 3 absorbers demonstrated strong broadband absorption in the visible–near-infrared range, validating their efficiency as photon harvesters. The optimized Sb 2 Se 3 -based configurations with CZGS and CBTS achieved band-edge responses up to ∼ 1050 nm and delivered the highest efficiencies of 26.38% and 25.92%, respectively, surpassing Spiro-OMeTAD-based devices (24.18%), whereas CFTS yielded only 9.67%. Parasitic resistance analysis further confirmed that increasing series resistance ( R s ) and decreasing shunt resistance ( R sh ) degrade the fill factor (FF) and power conversion efficiency (PCE), consistent with established photovoltaic models. Varying HTL thickness between 20 and 200 nm showed negligible impact once uniform, pinhole-free coverage was achieved, confirming that intrinsic material properties dominate device performance. Comparison with published reports reinforces the validity and credibility of our proposed design. Overall, the results identify CZGS and CBTS as highly promising kesterite-based HTLs, and the earth-abundant, non-toxic nature of these compounds underscores their potential for sustainable, high-efficiency AC solar cell development.
Förderung
- Universiti Teknologi Malaysia
- Potential Academic Staff
Zitieren
APA
Ibrahim, M. H., & Abdullah, A. S. (2025). First simulation-based evaluation of kesterite as a hole transport layer in antimony chalcogenide solar cells. Physica Scripta, 100(12), 125534. https://doi.org/10.1088/1402-4896/ae296f
Vancouver
Ibrahim MH, Abdullah AS. First simulation-based evaluation of kesterite as a hole transport layer in antimony chalcogenide solar cells. Physica Scripta. 2025;100(12):125534. doi:10.1088/1402-4896/ae296f
BibTeX
@article{Ibrahim2025,
author = {Ibrahim, Mohd Haniff and Abdullah, Ahmad Sharmi},
title = {First simulation-based evaluation of kesterite as a hole transport layer in antimony chalcogenide solar cells},
journal = {Physica Scripta},
year = {2025},
volume = {100},
number = {12},
pages = {125534},
doi = {10.1088/1402-4896/ae296f}
}
EUVIMED